To explore the effect of the method of resolving phlegm and lowering Qi in the treatment of polycystic ovary syndrome(PCOS) with liver depression and Qi stagnation syndrome, and its influence on glucose and lipid metabolism and sex hormone levels.
A total of 105 PCOS patients with phlegm-dampness obstruction syndrome who were treated in the endocrinology department of our hospital from June 2022 to December 2024 were selected and randomly divided into the experimental group(n=53, treated with the method of resolving phlegm and lowering Qi combined with clomiphene) and the control group(n=52, treated with clomiphene). The clinical efficacy,glycolipid metabolism, sex hormones, body mass index(BMI), waist-to-hip ratio(WHR), and the occurrence of adverse reactions were compared between the two groups.
The total effective rate of the experimental group was higher than that of the control group(90.57% vs. 75.00%, P<0.05). The levels of triglycerides, total cholesterol, fasting plasma glucose and fasting plasma insulin in both groups were lower than before(P<0.05), and the levels in the experimental group were lower than those in the control group(P<0.05). The levels of follicle-stimulating hormone, luteinizing hormone and testosterone in both groups were lower than before(P<0.05), and the levels in the experimental group were lower than those in the control group(P<0.05). After treatment, the BMI, WHR and traditional Chinese medicine syndrome scores of both groups decreased compared with before(P<0.05), and the scores of the experimental group were lower than those of the control group(P<0.05). The adverse reactions in the two groups mainly included stomachache,nausea and vomiting, and lower pelvic abdominal pain, etc., but there was no significant difference(P>0.05).
The addition of the method of resolving phlegm and lowering Qi in the treatment of PCOS patients with liver depression and Qi stagnation syndrome has a good effect. It can effectively improve glucose and lipid metabolism and sex hormone levels without increasing safety risks.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |